Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 18,156
- Companies
- 1,062
- Drugs tracked
- 3,187
Quick answer
NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
Placebo to 100mg masitinib, Placebo to 200mg masitinib, masitinib, masitinib
AB Science
Mastocytosis
1 trial -
RILUTEK 50 mg film-coated tablets, masitinib, Placebo to 200mg masitinib, masitinib, Riluzole Zentiva 50 mg film-coated tablets, Placebo to 100mg masitinib
AB Science
Amyotrophic Lateral Sclerosis
1 trial -
masitinib, Placebo to 200mg masitinib, Placebo to 100mg masitinib, masitinib
AB Science
Amyotrophic Lateral Sclerosis
1 trial -
masitinib, Placebo to 200mg masitinib, Placebo to 100mg masitinib, masitinib
AB Science
Multiple Sclerosis
1 trial -
AB8939, Vidaza 25 mg/ml powder for suspension for injection, Venclyxto 100 mg film-coated tablets
AB Science
Acute Myeloid Leukemia
1 trial -
masitinib, masitinib, Placebo to 100mg masitinib, Placebo to 200mg masitinib
AB Science
Mast cell activation syndrome
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources